Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal epithelial mucus components form a complex, multi-layered hydrogel that serves as the primary physical and chemical barrier between the gut lumen and the underlying epithelium (Johansson & Hansson, 2016, Nature Reviews Immunology). This system is predominantly composed of the large, gel-forming glycoprotein Mucin-2 (MUC2), which is secreted by specialized goblet cells and undergoes massive expansion upon release to create a protective matrix (Bansil & Turner, 2018, Advanced Drug Delivery Reviews). In the colon, this barrier consists of a dense inner layer that is virtually sterile and a loose outer layer that provides a habitat for the commensal microbiota (McGuckin et al., 2011, Nature Reviews Microbiology). Beyond structural support, these components integrate antimicrobial peptides and immunoglobulins to regulate host-microbe interactions and prevent the translocation of pathogens. Dysregulation or depletion of these mucus components is a central feature of inflammatory bowel diseases, such as ulcerative colitis, where the loss of barrier integrity leads to chronic inflammation (Kim & Ho, 2010, Current Gastroenterology Reports). Therapeutic targeting of these components involves the use of mucolytics to reduce viscosity in obstructive conditions or the administration of mucosal protectants and secretagogues to reinforce the barrier in inflammatory states.
Cleavage of disulfide bonds in mucin polymers (mucolysis); stimulation of prostaglandin-mediated mucus secretion; physical adherence to the mucosal surface to provide a protective barrier; replenishment of the phospholipid component of the mucus layer.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial mucus components.